The ESX-5 secretion system of mycobacterium marinum modulates the macrophage response

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7166-7175

  Abdallah, Abdallah M ^a,c   Savage, Nigel D L ^b   Van Zon, Maaike ^c   Wilson, Louis ^b   Vandenbroucke Grauls, Christina M J E ^a   Van Der Wel, Nicole N ^a,c   Ottenhoff, Tom H M ^b   Bitter, Wilbert ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; ESX 5 PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEMBRANE ANTIGEN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARRIER PROTEIN; VIRULENCE FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSOL; ELECTRON MICROSCOPY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MODULATION; MYCOBACTERIUM MARINUM; NONHUMAN; PHAGOLYSOSOME; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUBERCULOSIS; WILD TYPE; ATYPICAL MYCOBACTERIOSIS; BIOSYNTHESIS; CELL CULTURE; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

BACTERIAL PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOBLOTTING; MACROPHAGES; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; VIRULENCE FACTORS;

EID: 58149179178     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7166     Document Type: Article

References (53)

1. Finlay, B. B., and P. Cossart. 1997. Exploitation of mammalian host cell functions by bacterial pathogens. Science 276: 718-725.
2. Armstrong, J. A., and P. D. Hart. 1975. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle-bacilli: reversal of usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142: 1-16.
3. Wallis, R. S., and J. J. Ellner. 1994. Cytokines and tuberculosis. J. Leukocyte Biol. 55: 676-681.
4. Fenton, M. J., and M. W. Vermeulen. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64: 683-690.
5. Orme, I. M., and A. M. Cooper. 1999. Cytokine chemokine cascades in immunity to tuberculosis. Immunol. Today 20: 307-312.
6. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
7. van Crevel, R., T. H. M. Ottenhoff, and J. W. M. van der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15: 294-309.
8. Ottenhoff, T. H. M., F. A. W. Verreck, E. G. R. Lichtenauer-Kaligis, M. A. Hoeve, O. Sanal, and J. T. van Dissel. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32: 97-105.
9. Raja, A. 2004. Immunology of tuberculosis. Ind. J. Med. Res. 120: 213-232.
10. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740. (Pubitemid 19082507)
11. Senaldi, G., S. Yin, C. L. Shaklee, P. F. Piguet, T. W. Mak, and T. R. Ulich. 1996. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guérin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J. Immunol. 157: 5022-5026. (Pubitemid 126449582)
12. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. E. Kaufmann. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65: 4843-4849.
13. Giacomini, E., E. Iona, L. Ferroni, M. Miettinen, L. Fattorini, G. Orefici, I. Julkunen, and E. M. Coccia. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166: 7033-7041. (Pubitemid 32525572)
14. Nau, G. J., J. F. L. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99: 1503-1508.
15. van de Vosse, E., M. A. Hoeve, and T. H. Ottenhoff. 2004. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 4: 739-749.
16. Falcone, V., E. B. Bassey, A. Toniolo, P. G. Conaldi, and F. M. Collins. 1994. Differential release of tumor necrosis factor-α from murine peritoneal macrophages stimulated with virulent and avirulent species of mycobacteria. FEMS Immunol. Med. Microbiol. 8: 225-232. (Pubitemid 24097633)
17. Beltan, E., L. Horgen, and N. Rastogi. 2000. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb. Pathog. 28: 13-318.
18. Abdallah, A. M., N. C. Gey Van Pittius, P. A. Champion, J. Cox, J. Luirink, C. M. Vandenbroucke-Grauls, B. J. Appelmelk, and W. Bitter. 2007. Type VII secretion: mycobacteria show the way. Nat. Rev. Microbiol. 5: 883-891.
19. Skjot, R. L. V., T. Oettinger, I. Rosenkrands, P. Ravn, I. Brock, S. Jacobsen, and P. Andersen. 2000. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect. Immun. 68: 214-220.
20. Pym, A. S., P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K. E. Griffiths, G. Marchal, C. Leclerc, and S. T. Cole. 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9: 533-539.
21. Stanley, S. A., S. Raghavan, W. W. Hwang, and J. S. Cox. 2003. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc. Natl. Acad. Sci. USA 100: 13001-13006.
22. Gao, L. Y., S. Guo, B. McLaughlin, H. Morisaki, J. N. Engel, and E. J. Brown. 2004. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53: 1677-1693.
23. Pathak, S. K., S. Basu, K. K. Basu, A. Banerjee, S. Pathak, A. Bhattacharyya, T. Kaisho, M. Kundu, and J. Basu. 2007. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8: 610-618.
24. Brodin, P., I. Rosenkrands, P. Andersen, S. T. Cole, and R. Brosch. 2004. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12: 500-508. (Pubitemid 39370732)
25. van der Wel, N., D. Hava, D. Houben, D. Fluitsma, M. van Zon, J. Pierson, M. Brenner, and P. J. Peters. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129: 1287-1298. (Pubitemid 46962098)
26. Abdallah, A. M., T. Verboom, F. Hannes, M. Safi, M. Strong, D. Eisenberg, R. J. P. Musters, C. M. J. E. Vendenbroucke-Grauls, B. J. Appelmelk, J. Luirink, et al. 2006. A specific secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol. Microbiol. 62: 667-679.
27. Brennan, M. J., C. Espitia, and N. Gey von Pittius. 2004. The PE and PPE multigene families of Mycobacterium tuberculosis. S. Cole, D. N. McMurray, K. Eisenach, B. Gicquel, and W. R. Jacobs, eds. ASM Press, Washington, DC., pp. 513-525.
28. Ramakrishnan, L., N. A. Federspiel, and S. Falkow. 2000. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288: 1436-1439. (Pubitemid 30366332)
29. Li, Y. J., E. Miltner, M. Wu, M. Petrofsky, and L. E. Bermudez. 2005. A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice. Cell. Microbiol. 7: 539-548.
30. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, III, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
31. Banu, S., N. Honore, B. Saint-Joanis, D. Philpott, M. C. Prevost, and S. T. Cole. 2002. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol. Microbiol. 44: 9-19. (Pubitemid 34429761)
32. Brennan, M. J., and G. Delogu. 2002. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol. 10: 246-249.
33. Delogu, G., and M. J. Brennan. 2001. Comparative immune response to PE and PE-PGRS antigens of Mycobacterium tuberculosis. Infect. Immun. 69: 5606-5611. (Pubitemid 32786497)
34. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565.
35. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118. (Pubitemid 24091769)
36. Verreck, F. A., T. de Boer, D. M. Langenberg, Z. L. van der, and T. H. Ottenhoff. 2006. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J. Leukocyte Biol. 79: 285-293.
37. Mayhew, T. M., J. M. Lucocq, and G. Griffiths. 2002. Relative labelling index: a novel stereological approach to test for non-random immunogold labelling of organelles and membranes on transmission electron microscopy thin sections. J. Microsc. 205: 153-164.
38. Stamm, L. M., J. H. Morisaki, L. Y. Gao, R. L. Jeng, K. L. McDonald, R. Roth, S. Takeshita, J. Heuser, M. D. Welch, and E. J. Brown. 2003. Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J. Exp. Med. 198: 1361-1368.
39. Lee, B. Y., D. L. Clemens, and M. A. Horwitz. 2008. The metabolic activity of Mycobacterium tuberculosis, assessed by use of a novel inducible GFP expression system, correlates with its capacity to inhibit phagosomal maturation and acidification in human macrophages. Mol. Microbiol. 68: 1047-1060.
40. Peters, P. J., E. Bos, and A. Griekspoor. 2006. Cryo-immunogold electron microscopy. Curr. Protoc. Cell Biol. 4: Unit 4.7.
41. Gercken, J., J. Pryjma, M. Ernst, and H. D. Flad. 1994. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62: 3472-3478. (Pubitemid 24232135)
42. Noss, E. H., C. V. Harding, and W. H. Boom. 2000. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201: 63-74.
43. Sendide, K., A. E. Deghmane, J. M. Reyrat, A. Talal, and Z. Hmama. 2004. Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface. Infect. Immun. 72: 4200-4209. (Pubitemid 38821934)
44. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor-necrosis-factor-α required as a costimulatory factor for interferon-γ-induced activation. Proc. Natl. Acad. Sci. USA 89: 8676-8680.
45. Hmama, Z., R. Gabathuler, W. A. Jefferies, G. de Jong, and N. E. Reiner. 1998. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161: 4882-4893. (Pubitemid 28492067)
46. Fattorini, L., Y. Xiao, B. Li, C. Santoro, F. Ippoliti, and G. Orefici. 1994. Induction of IL-1β, IL-6, TNF-α, GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium. J. Med. Microbiol. 40: 129-133. (Pubitemid 2043026)
47. Stauffer, F., E. P. Petrow, H. Burgmann, W. Graninger, and A. Georgopoulos. 1994. Release of TNF α and IL6 from human monocytes infected with Mycobacterium kansasii: a comparison to Mycobacterium avium. Infection 22: 326-329. (Pubitemid 24316417)
48. Liew, F. Y., D. M. Xu, E. K. Brint, and L. A. J. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
49. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell. 10: 417-426. (Pubitemid 35007355)
50. Ogura, Y., F. S. Sutterwala, and R. A. Flavell. 2006. The inflammasome: first line of the immune response to cell stress. Cell 126: 659-662. (Pubitemid 44233635)
51. Hersh, D., D. M. Monack, M. R. Smith, N. Ghori, S. Falkow, and A. Zychlinsky. 1999. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. USA 96: 2396-2401. (Pubitemid 29117926)
52. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218. (Pubitemid 38902430)
53. Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran, R. Athman, S. Memet, M. R. Huerre, A. J. Coyle, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5: 1166-1174. (Pubitemid 39549631)